Antibe Therapeutics Inc(Pre-Merger) ATBPF

Healthcare Biotechnology

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.

GREY:ATBPF - Post by User

Antibe Therapeutics Inc(Pre-Merger) > Back Under $5

<< Previous

Bullboard Posts

Next >>

Comment by Inthepezon Mar 17, 2021 9:14am

107 Views

Post# 32815098

RE:RE:Back Under $5

Haha yes you made money when you tried to swing trade and got caught with your pants down. You ended up buying high, you turd haha. You can’t time the market. Dumpster tried and failed miserably. Now that he sold for pennies, he’s going to bash management, the stock, and give us lie and lie.

Duster340 wrote: it,s the smart investors that are dumping shares, we are making a killing on the swings in the stock price we love the volatility. pez is to stupid to figure out what is going on, and does not know how to make $$$. why are you here pez? i am here to make money

<< Previous

Bullboard Posts

Next >>

Canadian government to fund Electric Royalties portfolio property